Tag: Hudson Institute
ASX biotech firm Noxopharm unveils anti-inflammatory skin disease drug
Australian biotech company Noxopharm Limited unveiled today its new preclinical product candidate from its Sofra technology platform that has shown effectiveness against inflammatory skin disease in preclinical models
Featured Article
AI & Manufacturing Month with Australian Manufacturing
As industries around the globe embrace the digital revolution, artificial intelligence (AI) is rapidly transforming the manufacturing landscape.Â
